We plan to expand this study to include other functionally critical residues in Sema4A, their combinations, and explore the functional activity of novel mutant Sema4A proteins to treat asthma and, potentially, other chronic inflammatory conditions where Treg cells play essential regulatory roles. This evidence concerns the gene SEMA4A and asthma.